by TractManager | Jan 31, 2022 | Emerging Technology Report
Blarcamesine (proposed name: Anavex 2-73) is an investigational, orally available small molecule that acts as a muscarinic agonist and an agonist of the intracellular sigma-1 chaperone protein. It is in development for the treatment of early Alzheimer disease. If you...
by TractManager | Jan 31, 2022 | Emerging Technology Report
Donanemab is an investigational, intravenously administered amyloid beta-directed antibody proposed for the treatment of Alzheimer disease.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jan 27, 2022 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the TruGraf test for kidney transplant rejection.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jan 20, 2022 | Emerging Technology Report
The Revivent TC Transcatheter Ventricular Enhancement System is a micro-anchor and tether system intended for minimally invasive left ventricular (LV) restoration in patients with LV scar/aneurysm and heart failure.If you have a Hayes login, click here to view the...
by TractManager | Jan 19, 2022 | Emerging Technology Report
The OCS Liver is a portable extracorporeal liver perfusion and monitoring system indicated for preservation and monitoring of hemodynamics and metabolic function which allows for ex-vivo assessment of liver allografts from donors after brain death (DBD) or liver...
Recent Comments